Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

December 18, 2017

Study Completion Date

December 18, 2017

Conditions

Chronic Hepatitis C

Trial Locations (7)

Specialized Clinical Infectiou, Krasnodar

GBOU VPO Saratov state Med Uni, Saratov

Ulyanovsk Regional Clin Hosp, Ulyanovsk

LLC Medical Company, Samara

South-Ural State Med. Academy, Chelyabinsk

Orenburg Regional Clinical Hos, Orenburg

KOGBUZ Kirovsk Infect Hosp, Kirov